EMA — authorised 16 April 2018
- Marketing authorisation holder: ROCHE REGISTRATION LIMITED, UK
- Status: approved
EMA authorised Polivy on 16 April 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 16 April 2018.
ROCHE REGISTRATION LIMITED, UK holds the EU marketing authorisation.